Sigma Blames Fall In Generics Sales For 2010 Losses After 2009 Profits
This article was originally published in PharmAsia News
Executive Summary
Sigma Pharmaceuticals of Australia reported deteriorating financial conditions to the stock market, saying its generic-drug sales have failed to hold their own in a highly competitive market